ADAI Small Grants Program
Next application deadline: October 15, 2024
Purpose
The Addictions, Drug & Alcohol Institute (formerly the Alcohol & Drug Abuse Institute) works to stimulate and facilitate UW research on alcohol and drug use and addiction through its Small Grants Program, which awards funds to UW researchers for pilot studies and developmental research. The scope ranges from pharmacology of drugs to studies of clinical treatment strategies, prevention, and social policy issues. UW researchers should consider the Small Grants Program as a resource to help develop research through initial funding for promising pilot projects which may ultimately be developed into full studies with outside funding.
Deadlines each year are typically mid-March and mid-October. The next deadline is October 15, 2024.
- Award limit: $30,000 to faculty and research scientists; $20,000 to mentored predoctoral students and postdoctoral fellows.
- Full RFA available here.
Funded Projects
Since 1973, ADAI has awarded nearly $5,000,000 to researchers in more than 40 departments at the University of Washington. Currently, two levels of funding are available: faculty and research scientists may apply for funding up to $30,000; mentored predoctoral students and postdoctoral fellows may receive up to $20,000.
View previously funded awards:
Review Process
There are two grant cycles each year (deadlines approximately March 15 and October 15 – if the date falls on a weekend, the deadline will be the following Monday). Funding decisions are based on scientific merit assessed by peer review, relevance of the question to the field, innovation, and potential for new insights into the problems of substance use. Anonymous comments from the reviewers are returned to the investigators to provide constructive feedback, which is often used to improve a non-funded grant for future re-submission. For more information about submission and review process and criteria see the Request for Proposals (RFA).
Benefits to the University
The ADAI Small Grants Program has made a significant impact on the University and the field of alcohol and drug research and study overall: many millions of dollars in funding from NIH and other sponsors have been awarded to UW researchers who conducted pilot work using ADAI funds. Published articles, presentations, and support for graduate student research are additional outcomes of this funding. These results are noted in the descriptions of Previously Funded Small Grants (sidebar to the right).
For more information: Email ADAI or John F. Neumaier, MD, PhD (Professor, UW Psychiatry & Behavioral Sciences), Director of the ADAI Small Grants Program
